Targeting Human Gastrointestinal Stromal Tumour Cells with a Quadruplex-binding Small Molecule

The majority of human gastrointestinal stromal tumours (GIST) are driven by activating mutations in the proto-oncogene KIT, a tyrosine kinase receptor. Clinical treatment with imatinib targets the kinase domain of KIT, but tumour regrowth occurs as a result of the development of resistant mutations...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Gunaratnam, Mekala, Beltran, Monica, Galesa, Katja, Haider, Shozeb M., Reszka, Anthony P., Cuenca, Francisco, Fletcher, Jonathan A., Neidle, Stephen
Médium: Artigo
Jazyk:Inglês
Vydáno: 2009
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2900250/
https://ncbi.nlm.nih.gov/pubmed/19469547
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/jm900424a
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky